|Videos|June 24, 2020

Applying Cancer Knowledge to COVID Vaccine Research

Author(s)Contagion&reg Editorial Staff

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

Segment Description: Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

Part 1: SARS-CoV-2 Vaccine: Does Nucleocapsid DNA Lead to Lasting Protection?

Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, explains why the firm's SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.

Part 2: Goals of Operation Warp Speed

Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.

Part 3: Justice & American Values During the Coronavirus Pandemic

Patrick Soon-Shiong, MD, Chairman & CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Related to this article

September 3rd, 2026

Latest Vaccine and Immunization Efficacy, Safety for RSV, Influenza, and COVID-19

The Vaccine Integrity Project, in collaboration with the American Medical Association, conducted a vaccine and immunization effectiveness and safety review for RSV, Influenza, and COVID-19 for the 2026-2027 season. JAMA published the review, and here is an overview of the data going into this year's seasonal respiratory virus season.

September 16th, 2026

A Pennsylvania Teen Dies From Rare Measles Neurological Complication

The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.

September 14th, 2026

In the Midst of an Outbreak, Another Measles-Related Death Reported in Pennsylvania

The death was reported in Jefferson County where the coroner released a statement announcing it was in an unvaccinated woman.

September 10th, 2026

FAQ: What You Need to Know About 2026-2027 COVID-19 Vaccines

FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax's partners, all reformulated to target the XFG variant, giving clinicians several options ahead of the fall respiratory virus season.

September 1st, 2026

GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial

GSK will advance its investigational mRNA seasonal flu vaccine candidate, which targets both hemagglutinin and neuraminidase, into a phase 3 trial in September 2026 after the shot outperformed licensed flu vaccines in a phase 2 study.

August 28th, 2026

FDA Approves Multiple COVID-19 Vaccines With Protection Against XFG variant

The FDA has approved formulations for the 2026-2027 vaccines including Pfizer-BioNTech's Comirnaty XFG, Novavax's commercial partners Sanofi and Takeda have secured approvals for its Nuvaxovid, and Moderna's Spikevax and mNEXSPIKE vaccines, all with protections against the currently circulating variant.

August 27th, 2026

FDA Approves 2026-2027 Pfizer-BioNTech COVID-19 Vaccine

The FDA has approved Pfizer-BioNTech's 2026-2027 Comirnaty XFG formula, an updated COVID-19 vaccine targeting the XFG variant, for adults 65 and older and for individuals ages five through 64 with at least one high-risk underlying condition.

August 27th, 2026

Clinical Insights and the Geopolitics Surrounding the Ongoing Ebola Outbreak

Gavin Harris, MD, provides some context around what is happening in the Democratic Republic of Congo regarding the outbreak including the country’s inherent challenges as well as discussing the latest in testing, vaccines, and treatments of this rare strain of Ebola.

Applying Cancer Knowledge to COVID Vaccine Research

Related to this article

Trending on Contagion Live

A Pennsylvania Teen Dies From Rare Measles Neurological Complication

Ceftriaxone Safety: Separating Signal From Risk

Revisiting Whether Cefepime Raises Mortality Risk

New York City Orders Tower Cleanings, Announces Prevention Measures in Addressing Legionnaires' Disease Cluster

New Diagnositics for Legionella Pneumonia May Streamline Care Continuum